Pretraga
Rezultati
Obesity - risk factor for doctors' health [2009]
Vukadinovic, Nada; Cimbaljevic, BrankoCardiovascular outcomes associated with achieved haemoglobin level and preliminary rate of rise of haemoglobin in pooled phase 3 studies of roxadustat in non-dialysis-dependent patients with anaemia [2021]
Barratt, Jonathan; Sulowicz, Wladyslaw; Cockburn, Elinor; Reusch, Michael; Young, James; Dimkovic, Nada BClinical efficacy of atezolizumab (atezo) in biomarker subgroups by PD-L1 immunohistochemistry (IHC) assays and blood tumour mutational burden (bTMB): IMpower110 [2020]
Herbst, Roy S; ...; Andric, Zoran GGrowth differentiation factor 15, a potential biomarker and a therapeutic target in myeloproliferative neoplasms
[2023]
Uda, Narasimha Rao; ...; Leković, Danijela R. Roxadustat for the treatment of anemia in chronic kidney disease (CKD) patients not on dialysis (NDD): a phase 3, randomized, open-label, active-controlled study [2020]
Barratt, Jonathan; Andric, Branislav R; Tataradze, Avtandil; Schoemig, Michael; Reusch, Michael; Valluri, UdayaBody mass index and asthma severity
[2008]
Joci-Stojanovic, Jasmina; Zivković, Zorica M.; Radić, Snežana D.; Cerović, Snežana J Body mass index and atopic disease [2008]
Cerovic, Sofija; Zivkovic, Zorica M; Radic, Snezana D; Jocic-Stojanovic, Jasmina; Rodic, V; Bajec-Opancina, Aleksandra A; Gavrilovic, T; Veljkovic, PLymphopenia is highly prevalent in MDS and provides prognostic information for IPSS-R (very)-low-risk patients. An analysis from the EU-MDS registry [2021]
Silzle, T; ...; Savic, Aleksandar DIron Parameters in Patients Treated With Roxadustat for Anemia Associated With Chronic Kidney Disease: Post Hoc Analysis of the Non-Dialysis-Dependent or Incident Dialysis Population From Four Phase 3 Studies [2022]
Esposito, Ciro; Barratt, Jonathan; Dellanna, Frank; Portoles, Jose; Choukroun, Gabriel; De, Nicola Luca; Reusch, Michael; Young, James; Jiletcovici, Alina; Dimkovic, Nada BPooled efficacy and cardiovascular safety results of roxadustat compared with placebo/ darbepoetin alfa for treatment of anaemia in patients with non-dialysis-dependent (NDD) chronic kidney disease (CKD) [2021]
Barratt, Jonathan; Dimkovic, Nada B; Shutov, Evgeny; Sulowicz, Wladyslaw; Esposito, Ciro; Reusch, Michael; Young, James; Mariat, ChristopheFilteri
Po tipu
- 16